Institutional
Venrock Adviser, LLC
CIK 0001615982
$2.68B
Reported AUM
33
Positions
Q1 2026
Period
2026-05-15
Filed
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | APGE | APOGEE THERAPEUTICS INC | $86.92 | -4.38% | 112.10% | 278.90% | $714.9M | 26.68% | — | HELD |
| 2 | ERAS | ERASCA INC | $11.97 | -9.80% | 648.13% | -49.94% | $265.1M | 9.89% | −1,474,271 | −8.3% |
| 3 | ORKA | ORUKA THERAPEUTICS INC | $60.14 | -3.44% | 378.06% | 194.89% | $203.5M | 7.60% | — | HELD |
| 4 | SYRE | SPYRE THERAPEUTICS INC | $73.65 | -6.15% | 334.00% | -51.94% | $185.9M | 6.94% | — | HELD |
| 5 | KALV | KALVISTA PHARMACEUTICALS INC | $26.95 | 0.00% | 87.61% | 33.81% | $130.3M | 4.86% | −254,500 | −3.8% |
| 6 | DNTH | DIANTHUS THERAPEUTICS INC | $80.51 | -4.30% | 327.11% | -29.33% | $99.0M | 3.70% | +180,000 | +18.0% |
| 7 | DMRA | DAMORA THERAPEUTICS INC | $21.01 | -5.83% | 538.60% | -80.41% | $93.3M | 3.48% | +3,603,595 | NEW |
| 8 | OCUL | OCULAR THERAPEUTIX INC | $8.25 | -6.25% | -8.54% | -25.07% | $87.6M | 3.27% | +3,031,379 | +41.4% |
| 9 | COGT | COGENT BIOSCIENCES INC | $31.02 | -5.40% | 356.18% | 417.00% | $77.0M | 2.87% | — | HELD |
| 10 | VRDN | VIRIDIAN THERAPEUTICS INC | $15.78 | -4.77% | 7.49% | 1.64% | $75.9M | 2.83% | — | HELD |
| 11 | SVRA | SAVARA INC | $5.09 | -3.96% | 108.61% | 297.66% | $75.0M | 2.80% | — | HELD |
| 12 | ELVN | ENLIVEN THERAPEUTICS INC | $33.97 | -2.13% | 67.36% | 60.99% | $67.7M | 2.53% | −1,500,000 | −46.5% |
| 13 | ORIC | ORIC PHARMACEUTICALS INC | $7.50 | -6.48% | -19.53% | -54.95% | $54.7M | 2.04% | −1,356,465 | −23.9% |
| 14 | VOR | VOR BIOPHARMA INC | $13.16 | -8.10% | 193.75% | -94.74% | $54.3M | 2.03% | +1,097,953 | +56.5% |
| 15 | MAZE | MAZE THERAPEUTICS INC | $24.27 | -4.45% | 87.70% | 98.45% | $47.8M | 1.78% | +53,465 | +3.5% |
| 16 | CTMX | CYTOMX THERAPEUTICS INC | $3.00 | -5.66% | 13.64% | -44.55% | $46.9M | 1.75% | −5,579,376 | −35.9% |
| 17 | JBIO | JADE BIOSCIENCES INC | $16.94 | -4.51% | 135.61% | -96.13% | $45.2M | 1.69% | — | HELD |
| 18 | DYN | DYNE THERAPEUTICS INC | $17.04 | -7.44% | 15.92% | -5.70% | $39.4M | 1.47% | — | HELD |
| 19 | CBIO | CRESCENT BIOPHARMA INC. | $18.00 | -2.44% | -5.26% | -108.10% | $39.2M | 1.46% | — | HELD |
| 20 | ZURA | ZURA BIO LTD | $3.40 | -7.36% | 169.84% | -50.07% | $38.3M | 1.43% | +1,089,875 | +20.4% |
| 21 | RLMD | RELMADA THERAPEUTICS INC | $5.95 | -5.71% | 612.57% | -77.12% | $33.7M | 1.26% | +4,843,380 | NEW |
| 22 | — | ENGENE HOLDINGS INC | — | — | — | — | $32.5M | 1.21% | — | HELD |
| 23 | TENX | TENAX THERAPEUTICS INC | $10.73 | -3.25% | 77.06% | -99.61% | $26.8M | 1.00% | +1,675,262 | NEW |
| 24 | ANL | ADLAI NORTYE LTD | $9.58 | -3.72% | 488.09% | 19.01% | $22.2M | 0.83% | +3,212,731 | NEW |
| 25 | IPSC | CENTURY THERAPEUTICS INC | $2.13 | -3.18% | 245.78% | -92.69% | $19.7M | 0.73% | +8,695,652 | NEW |
| 26 | CGEM | CULLINAN THERAPEUTICS INC | $13.51 | -6.38% | 48.79% | -41.08% | $19.6M | 0.73% | — | HELD |
| 27 | HELP | CYBIN INC | $4.15 | -6.32% | -53.37% | -96.42% | $18.5M | 0.69% | +11,404 | +0.3% |
| 28 | SRZN | SURROZEN INC | $21.52 | -11.73% | 153.18% | -85.61% | $18.4M | 0.69% | — | HELD |
| 29 | SEPN | SEPTERNA INC | $31.15 | -0.70% | 205.09% | 23.17% | $12.2M | 0.45% | −104,752 | −17.1% |
| 30 | KRRO | KORRO BIO INC | $10.72 | -4.11% | -26.53% | -97.43% | $11.4M | 0.43% | +1,009,500 | NEW |
| 31 | ANRO | ALTO NEUROSCIENCE INC | $18.26 | -8.84% | — | — | $11.2M | 0.42% | +500,000 | NEW |
| 32 | ARTV | ARTIVA BIOTHERAPEUTICS INC | $6.81 | -0.60% | — | — | $10.4M | 0.39% | — | HELD |
| 33 | XFOR | X4 PHARMACEUTICALS INC | $3.83 | -4.49% | — | — | $1.4M | 0.05% | +330,525 | NEW |
| 34 | UPB | UPSTREAM BIO INC | $7.05 | -5.11% | — | — | — | — | −1,169,298 | EXITED |
| 35 | CASIF | CASI PHARMACEUTICALS INC | $0.13 | 18.18% | — | — | — | — | −987,259 | EXITED |
Source: SEC EDGAR · accession 0001615982-26-000011. 13F discloses long positions only — shorts, foreign equities, and options are excluded.